dostarlimab - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial AUST R: 352631 Active ingredients: dostarlimab Dosage form: Injection, intravenous infusion Sponsor: GlaxoSmithKline Australia Pty Ltd Phone: 1800 033 019	From 15 Jul 2024 to 31 Dec 2024	Shortage status: Current Availability: Limited Availability Reason: Unexpected increase in consumer demand Management action: Sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.

Product details

Supply Impact Dates

Further Details

JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial
AUST R: 352631
Active ingredients:
dostarlimab

Dosage form:
Injection, intravenous infusion

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800 033 019

From
15 Jul 2024
to
31 Dec 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
Sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.